Show news: from last 30 days (default), 60 days, 90 days, last visit or all

PCF6 book in demand!

8th March 2018

Demand for PCF6 print version has been high and has exhausted stocks on two occasions and we have today ordered a third print run. Although we have attempted to maintain a consistent supply, issues out of our control have led to delays developing between order placement and order fulfilment.

We apologise for any inconvenience caused and would like to reassure members that all current orders will be dealt with as soon as possible. If you are awaiting an order, you will be e-mailed when your book has been despatched.

We have only one part-time administrator to deal with all the orders and we are grateful for your patience and ongoing support.

Retirement lunch for Robert Twycross

14th February 2018

Following the announcement of his retirement as joint Editor-in-Chief of the Palliative Care Formulary, (see our news item), a retirement luch was held for Robert Twycross. A personalized leather-bound copy of PCF6 and IPC5 were presented, along with an engraved pen set and words of appreciation/anecdotes provided by members of Photographs were taken to mark the occasion. In the picture below, from left to right are:

Back row: Dr Claire Stark-Toller (PCF6 Editor), Dr Andrew Wilcock (PCF6 Editor-in-Chief), Dr Robert Twycross (PCF6 Editor-in-Chief), Dr Paul Howard (PCF6 Editor-in-Chief), Sarah Charlesworth (PCF6 Senior Editor)

Front row: Sarah Keeling (Production editor), Karen Isaac (Secretary), Julie Mortimer (PCF6 Associate Editor).

Retirement lunch photograph

Hyoscine butylbromide ampoules (Buscopan) shortage - UPDATE

6th February 2018

There is a national shortage of hyoscine butylbromide injection (Buscopan) in the UK, as Sanofi (the sole supplier of this product) is out of stock. New supplies are expected by the end of this week (5th February 2018). However, some units have already run out of stock. Glycopyrronium injection can be considered as an unauthorized alternative in the palliative care seting for the management of inoperable intestinal obstruction or as an antispasmodic. See PCF6 Antimuscarinics and PCF6 Glycopyrronium monographs for more detail.

08/02/18 Update

Sanofi have confirmed that supplies of hyoscine butylbromide injection (Buscopan) have now been released and stock has been delivered to wholesalers throughout the UK on the 7th and 8th February 2018. It should be available for ordering within 24h. They have advised that the available volume is sufficient to meet normal UK requirements and that there should be no further delays to future delivery schedules. In order to prevent further strain on the supply chain they have asked that people refrain from excess ordering.

click here to view